Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

44.35EUR
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
€44.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,656,296
52-wk High
€69.90
52-wk Low
€38.28

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Company Address

Fresenius SE & Co KGaA

Else-Kroener-Str. 1
BAD HOMBURG VOR DER HOEHE     61352
P: +496172.6080

Company Web Links

Officers & Directors

Name Age Since Current Position

Gerd Krick

80 2003 Independent Chairman of the Supervisory Board

Stephan Sturm

56 2017 Chairman of the Management Board, Chief Executive Officer

Michael Diekmann

64 Independent Deputy Chairman of the Supervisory Board

Niko Stumpfoegger

63 2008 Independent Deputy Chairman of the Supervisory Board

Dieter Schenk

66 2007 Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant